(Q47889297)

English

Effect of memantine combination therapy on symptoms in patients with moderate-to-severe depressive disorder: randomized, double-blind, placebo-controlled study.

scientific article published on 3 November 2016

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27809351%20AND%20SRC:MED&resulttype=core&format=json

26 March 2020

Effect of memantine combination therapy on symptoms in patients with moderate-to-severe depressive disorder: randomized, double-blind, placebo-controlled study (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27809351%20AND%20SRC:MED&resulttype=core&format=json

26 March 2020

1 reference

based on heuristic

inferred from title

depressive disorder

1 reference

based on heuristic

inferred from title

Mahtab Roohi-Azizi

6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27809351%20AND%20SRC:MED&resulttype=core&format=json

26 March 2020

author name string

M Amidfar

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27809351%20AND%20SRC:MED&resulttype=core&format=json

26 March 2020

M Khiabany

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27809351%20AND%20SRC:MED&resulttype=core&format=json

26 March 2020

A Kohi

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27809351%20AND%20SRC:MED&resulttype=core&format=json

26 March 2020

E Salardini

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27809351%20AND%20SRC:MED&resulttype=core&format=json

26 March 2020

M Arbabi

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27809351%20AND%20SRC:MED&resulttype=core&format=json

26 March 2020

M-R Zarrindast

7

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27809351%20AND%20SRC:MED&resulttype=core&format=json

26 March 2020

P Mohammadinejad

8

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27809351%20AND%20SRC:MED&resulttype=core&format=json

26 March 2020

A Zeinoddini

9

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27809351%20AND%20SRC:MED&resulttype=core&format=json

26 March 2020

S Akhondzadeh

10

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27809351%20AND%20SRC:MED&resulttype=core&format=json

26 March 2020

publication date

3 November 2016

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27809351%20AND%20SRC:MED&resulttype=core&format=json

26 March 2020

Journal of Clinical Pharmacy and Therapeutics

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27809351%20AND%20SRC:MED&resulttype=core&format=json

26 March 2020

42

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27809351%20AND%20SRC:MED&resulttype=core&format=json

26 March 2020

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27809351%20AND%20SRC:MED&resulttype=core&format=json

26 March 2020

44-50

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27809351%20AND%20SRC:MED&resulttype=core&format=json

26 March 2020

The epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCS-R)

1 reference

https://api.crossref.org/works/10.1111%2FJCPT.12469

21 January 2018

NMDA Receptor Antagonists for Treatment of Depression

1 reference

https://api.crossref.org/works/10.1111%2FJCPT.12469

21 January 2018

Riluzole combination therapy for moderate-to-severe major depressive disorder: A randomized, double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1111%2FJCPT.12469

21 January 2018

Evaluation of outcomes with citalopram for depression using measurement-based care in STAR*D: implications for clinical practice

1 reference

https://api.crossref.org/works/10.1111%2FJCPT.12469

21 January 2018

The STAR*D Project results: a comprehensive review of findings.

1 reference

https://api.crossref.org/works/10.1111%2FJCPT.12469

21 January 2018

A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression

1 reference

https://api.crossref.org/works/10.1111%2FJCPT.12469

21 January 2018

Functional antagonists at the NMDA receptor complex exhibit antidepressant actions

1 reference

https://api.crossref.org/works/10.1111%2FJCPT.12469

21 January 2018

Pioglitazone adjunctive therapy for moderate-to-severe major depressive disorder: randomized double-blind placebo-controlled trial.

1 reference

https://api.crossref.org/works/10.1111%2FJCPT.12469

21 January 2018

Mirtazapine and paroxetine in major depression: a comparison of monotherapy versus their combination from treatment initiation

1 reference

https://api.crossref.org/works/10.1111%2FJCPT.12469

21 January 2018

Combination of antidepressant medications from treatment initiation for major depressive disorder: a double-blind randomized study.

1 reference

https://api.crossref.org/works/10.1111%2FJCPT.12469

21 January 2018

Combining norepinephrine and serotonin reuptake inhibition mechanisms for treatment of depression: a double-blind, randomized study

1 reference

https://api.crossref.org/works/10.1111%2FJCPT.12469

21 January 2018

Combining medications to enhance depression outcomes (CO-MED): acute and long-term outcomes of a single-blind randomized study.

1 reference

https://api.crossref.org/works/10.1111%2FJCPT.12469

21 January 2018

Metabotropic glutamate receptors: physiology, pharmacology, and disease

1 reference

https://api.crossref.org/works/10.1111%2FJCPT.12469

21 January 2018

Possible antidepressant effects and mechanisms of memantine in behaviors and synaptic plasticity of a depression rat model.

1 reference

https://api.crossref.org/works/10.1111%2FJCPT.12469

21 January 2018

Pharmacological properties of glutamatergic drugs targeting NMDA receptors and their application in major depression

1 reference

https://api.crossref.org/works/10.1111%2FJCPT.12469

21 January 2018

Memantine as adjunctive treatment to risperidone in children with autistic disorder: a randomized, double-blind, placebo-controlled trial.

1 reference

https://api.crossref.org/works/10.1111%2FJCPT.12469

21 January 2018

Emerging drugs for major depressive disorder

1 reference

https://api.crossref.org/works/10.1111%2FJCPT.12469

21 January 2018

Targeting of NMDA receptors in the treatment of major depression

1 reference

https://api.crossref.org/works/10.1111%2FJCPT.12469

21 January 2018

A double-blind, placebo-controlled study of memantine in the treatment of major depression

1 reference

https://api.crossref.org/works/10.1111%2FJCPT.12469

21 January 2018

Riluzole for relapse prevention following intravenous ketamine in treatment-resistant depression: a pilot randomized, placebo-controlled continuation trial

1 reference

https://api.crossref.org/works/10.1111%2FJCPT.12469

21 January 2018

Early antidepressant effect of memantine during augmentation of lamotrigine inadequate response in bipolar depression: a double-blind, randomized, placebo-controlled trial.

1 reference

https://api.crossref.org/works/10.1111%2FJCPT.12469

21 January 2018

Memantine is a clinically well tolerated N-methyl-D-aspartate (NMDA) receptor antagonist--a review of preclinical data

1 reference

https://api.crossref.org/works/10.1111%2FJCPT.12469

21 January 2018

Mechanism of action of memantine

1 reference

https://api.crossref.org/works/10.1111%2FJCPT.12469

21 January 2018

Memantine in moderate-to-severe Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1111%2FJCPT.12469

21 January 2018

Memantine treatment in patients with moderate to severe Alzheimer disease already receiving donepezil: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1111%2FJCPT.12469

21 January 2018

Neurochemical and behavioural effects of acute and chronic memantine administration in rats: Further support for NMDA as a new pharmacological target for the treatment of depression?

1 reference

https://api.crossref.org/works/10.1111%2FJCPT.12469

21 January 2018

Mechanisms underlying differential effectiveness of memantine and ketamine in rapid antidepressant responses

1 reference

https://api.crossref.org/works/10.1111%2FJCPT.12469

21 January 2018

Antidepressant augmentation using the N-methyl-D-aspartate antagonist memantine: a randomized, double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1111%2FJCPT.12469

21 January 2018

Targeting the glutamatergic system to develop novel, improved therapeutics for mood disorders

1 reference

https://api.crossref.org/works/10.1111%2FJCPT.12469

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJCPT.12469

21 January 2018

A rating scale for depression

1 reference

https://api.crossref.org/works/10.1111%2FJCPT.12469

21 January 2018

Oral scopolamine augmentation in moderate to severe major depressive disorder: a randomized, double-blind, placebo-controlled study.

1 reference

https://api.crossref.org/works/10.1111%2FJCPT.12469

21 January 2018

Minocycline add-on to risperidone for treatment of negative symptoms in patients with stable schizophrenia: randomized double-blind placebo-controlled study

1 reference

https://api.crossref.org/works/10.1111%2FJCPT.12469

21 January 2018

A randomized, double-blind, clinical trial comparing the efficacy and safety of Crocus sativus L. with fluoxetine for improving mild to moderate depression in post percutaneous coronary intervention patients.

1 reference

https://api.crossref.org/works/10.1111%2FJCPT.12469

21 January 2018

L-lysine as an adjunct to risperidone in patients with chronic schizophrenia: a double-blind, placebo-controlled, randomized trial.

1 reference

https://api.crossref.org/works/10.1111%2FJCPT.12469

21 January 2018

Pioglitazone adjunctive therapy for depressive episode of bipolar disorder: a randomized, double-blind, placebo-controlled trial.

1 reference

https://api.crossref.org/works/10.1111%2FJCPT.12469

21 January 2018

Therapeutic effects of minocycline on mild-to-moderate depression in HIV patients: a double-blind, placebo-controlled, randomized trial

1 reference

https://api.crossref.org/works/10.1111%2FJCPT.12469

21 January 2018

Antidepressant effects of ketamine in depressed patients

1 reference

https://api.crossref.org/works/10.1111%2FJCPT.12469

21 January 2018

Efficacy and safety of oral ketamine versus diclofenac to alleviate mild to moderate depression in chronic pain patients: A double-blind, randomized, controlled trial.

1 reference

https://api.crossref.org/works/10.1111%2FJCPT.12469

21 January 2018

An open-label, flexible-dose study of memantine in major depressive disorder.

1 reference

https://api.crossref.org/works/10.1111%2FJCPT.12469

21 January 2018

Identifiers

10.1111/JCPT.12469

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27809351%20AND%20SRC:MED&resulttype=core&format=json

26 March 2020

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27809351%20AND%20SRC:MED&resulttype=core&format=json

26 March 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q47889297&oldid=1865182861"